文献速递前列腺癌

徒手与三维模板映射活检在前列腺癌检测中的比较

Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men.
PubMed 文献 · J Urol · 2019-10-09

该回顾性研究比较了徒手系统性活检与磁共振-超声融合设备引导的三维模板映射活检在初次活检男性中的前列腺癌检出率。结果显示,模板映射活检检测到任何前列腺癌和临床显著癌的比例均显著高于徒手活检,提示其可能减少假阴性。

要点

  • 模板映射活检检测任何前列腺癌的比率为48.5%,徒手活检为41.0%(p=0.005)。
  • 模板映射活检检测临床显著前列腺癌的比率为37.0%,徒手活检为29.2%(p=0.002)。
  • 模板映射系统性活检在初次活检男性中检出更多前列腺癌,是有前景的替代方案。

核心结论

  • 在初次活检男性中,模板映射系统性活检比传统徒手采样检测到更多前列腺癌。

研究设计与样本

  • 回顾性研究纳入2006至2014年间1,582例初次活检男性,其中1,052例接受传统活检,530例接受磁共振-超声融合设备引导的模板活检。

主要发现

  • 模板活检组任何前列腺癌检出率为48.5%(257/530),临床显著癌为37.0%(196/530)。
  • 传统活检组任何前列腺癌检出率为41.0%(432/1,052)(p=0.005),临床显著癌为29.2%(308/1,052)(p=0.002)。
  • 两组患者年龄、前列腺特异性抗原和系统性穿刺针数相同。

临床怎么用

  • 模板映射系统性活检可作为磁共振-超声融合活检的一种有前景的成本效益替代方案,用于 upfront 筛查工具。

局限性

  • 研究为回顾性设计,可能存选择偏倚。
  • 排除既往活检或治疗及穿刺针数少于10针者,结果外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Targeted prostate biopsy devices include a 3-dimensional digital template grid to guide systematic biopsy locations. Following a template could better ensure uniform and well distributed sampling of the prostate compared to the traditional freehand biopsy approach, possibly decreasing the chance of false-negative biopsy. Thus, we determined cancer detection rates obtained by conventional freehand systematic sampling vs template mapping sampling using a magnetic resonance imaging-ultrasound fusion device. MATERIALS AND METHODS: Men who underwent first line conventional or image guided prostate biopsy were identified retrospectively in an institutional review board approved protocol. Excluded from study were men with prior biopsy or treatment or fewer than 10 cores taken. Targeted cores obtained by image guided biopsy were censored from analysis to simulate systematic template biopsy. The resulting cancer detection rate was compared to that of conventional biopsy. RESULTS: We identified 1,582 patients between 2006 and 2014 who met the criteria for analysis, including 1,052 who underwent conventional biopsy and 530 who underwent template biopsy with a magnetic resonance imaging-ultrasound fusion device. Patient age, prostate specific antigen and the number of systematic cores were the same in the 2 groups. Template biopsy detected any prostate cancer in 257 of 530 men (48.5%) and clinically significant cancer in 196 (37.0%) while conventional biopsy detected any cancer in 432 of 1,052 (41.0%) (p=0.005) and clinically significant cancer in 308 (29.2%) (p=0.002). CONCLUSIONS: Template mapping systematic biopsy detected more prostate cancer than conventional sampling in biopsy naïve men. It is a promising cost-effective alternative to magnetic resonance imaging-ultrasound fusion biopsy as an upfront screening tool.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Zhou SR, Chang E, Patankar A, et al. Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men. J Urol. 2019. PMID: 31596671. doi:10.1097/JU.0000000000000587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。